phosphine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiper, M; Weiss, E; Zuber, G | 1 |
| Duatti, A; Faintuch, BL; Faintuch, S; Muramoto, E; Smith, CJ; Teodoro, R | 1 |
1 review(s) available for phosphine and Disease Models, Animal
| Article | Year |
|---|---|
Biocompatible gold nanoclusters: synthetic strategies and biomedical prospects.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Fluorescent Dyes; Gold; Humans; Metal Nanoparticles; Molecular Imaging; Neoplasms; Particle Size; Phosphines; Radiation-Sensitizing Agents; Solubility; Staining and Labeling; Sulfhydryl Compounds; Water | 2019 |
1 other study(ies) available for phosphine and Disease Models, Animal
| Article | Year |
|---|---|
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Hydrazines; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Niacinamide; Nitrogen Compounds; Organotechnetium Compounds; Pancreas; Phosphines; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2008 |